9th Annual meeting of the International Cytokine and Interferon Society Meeting

美国国立卫生研究院对科学会议的支持-R13拨款申请 摘要 此应用程序的目的是请求为细胞因子2021混合会议提供资金支持：第9届年会 国际细胞因子和干扰素学会(ICIS)会议，2021年10月17日至20日在英国威尔士加的夫举行 同步虚拟会议平台，包括11月10日的实时流和点播访问， 2021年。这次年度会议有助于弥合从事分子基础研究的科学家之间的差距 以及免疫细胞激活和功能的细胞机制与那些致力于发展这一知识的人 变成了新的疗法。细胞因子和干扰素是免疫反应的有力效应者，也是主宰。 许多不同生理过程的调节者。这次会议的重点是将来自 生物医学研究的不同领域，讨论细胞因子和 干扰素调节免疫、炎症、新陈代谢和癌症。更好地理解和理解 疾病和新的治疗概念已经并将继续从多学科的聚会中涌现出来， 成熟的和实习的科学家可以介绍和讨论进展。 我们希望与会者能够更深入地了解细胞因子是如何相互联系在一起维持 并了解针对该网络创造更好的药物的许多潜在战略。 会议将为基础科学和临床研究的研究人员提供一个出色的论坛来介绍 他们关于细胞因子(包括干扰素、趋化因子和各种促细胞因子)作用的最新发现。 炎症/抗炎因子)在感染、癌症、过敏和自身免疫中，以及在其他各种疾病中 炎症性和免疫性疾病。会议还将提供一个机会，了解有关 在这些领域开发新的治疗干预措施，并帮助促进 会议参与者。 在线演示将与物理演示和包括虚拟交互的会议交织在一起， 实时评论、在线和视频聊天论坛、网络直播视频演示和个人机会 讨论。ICIS会议委员会和理事会已决定使用定制虚拟会议 平台即使在放宽旅行限制后，也将使年会更具包容性，并使 会议更具可持续性。 这是联合主席和当地组委会(由5名科学家、3名男性组成)的坚定信念 和2名女性)，通过将在以下领域工作的领导人、初级调查人员和受训人员聚集在一起 干扰素和细胞因子的研究，这次会议将启发重要的新的研究途径，并将 对细胞因子生物学领域有前途的年轻研究人员和实习生的职业发展大有裨益 菲尔德。

NIH Support for Scientific Conference – R13 Grant Application ABSTRACT The purpose of this application is to request financial support for the Cytokines 2021 Hybrid Meeting: 9th Annual Meeting of the International Cytokine & Interferon Society (ICIS), October 17-20, 2021 in Cardiff, Wales, UK with synchronous Virtual Meeting Platform including live streamed and on-demand access through November 10, 2021. This Annual Meeting helps bridge the gap between the scientists performing basic research on molecular and cellular mechanisms of immune cell activation and function with those working to develop this knowledge into novel therapies. Cytokines and interferons are potent effectors of an immune response and also are master regulators of many diverse physiologic processes. The focus of this meeting is to bring together scientists from diverse areas of biomedical research to discuss the latest breakthroughs and insights into how cytokines and interferons regulate immunity, inflammation, metabolism, and cancer. Greater understanding of mechanisms of disease and novel concepts for therapy have and will continue to emerge from multidisciplinary gatherings where advances can be presented and discussed by established and trainee scientists. It is our hope that attendees will gain a deeper understanding of how cytokines network together to maintain health and gain an appreciation for the many potential strategies for targeting the network to create better drugs. The meeting will provide an outstanding forum for investigators in basic science and clinical research to present their most recent findings on the role of cytokines (including interferons, chemokines, and various pro- inflammatory/anti-inflammatory factors) in infection, cancer, allergy and autoimmunity, as well as in various other inflammatory and immune diseases. The meeting will also provide an opportunity for updates on the development of novel therapeutic interventions in these fields and help spur international collaborations among the meeting participants. Online presentations will be intertwined with physical presentations and sessions including virtual interactions, live commentaries, online & video chat forums, webcast video presentations and opportunities for individual discussion. ICIS Meetings Committee and Council have decided that use of a customized Virtual Meeting Platform even after travel restrictions are relaxed, will make the Annual Meeting more inclusive and make the meetings more sustainable. It is the firm belief of the Co-Chairs and Local Organizing Committee (diversely composed of 5 scientists, 3 male and 2 female) that, by bringing together leaders, junior investigators, and trainees working in the area of Interferon and Cytokine research, this meeting will inspire important new avenues of investigation and will be of great benefit to the career development of promising young investigators and trainees in the cytokine biology field.